Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies
Background Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitoc...
Saved in:
| Published in | Journal of translational medicine Vol. 19; no. 1; pp. 214 - 15 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
17.05.2021
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1479-5876 1479-5876 |
| DOI | 10.1186/s12967-021-02878-3 |
Cover
| Abstract | Background
Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation.
Methods
We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis.
Results
Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI–associated myocardial dysfunction after cardiac surgery.
Conclusion
The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation.
Systematic review registration
The study was registered at UMIN under the registration number UMIN000043347. |
|---|---|
| AbstractList | Background Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation. Methods We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis. Results Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI–associated myocardial dysfunction after cardiac surgery. Conclusion The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Systematic review registration The study was registered at UMIN under the registration number UMIN000043347. Background Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation. Methods We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis. Results Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI-associated myocardial dysfunction after cardiac surgery. Conclusion The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Systematic review registration The study was registered at UMIN under the registration number UMIN000043347. Keywords: Systematic review, Mitochondria, Transplantation, Ischemia reperfusion injury, Translation science Background Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation. Methods We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis. Results Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI–associated myocardial dysfunction after cardiac surgery. Conclusion The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Systematic review registration The study was registered at UMIN under the registration number UMIN000043347. Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation. We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis. Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI-associated myocardial dysfunction after cardiac surgery. The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Systematic review registration The study was registered at UMIN under the registration number UMIN000043347. Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation. We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis. Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI-associated myocardial dysfunction after cardiac surgery. The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Abstract Background Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation. Methods We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis. Results Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI–associated myocardial dysfunction after cardiac surgery. Conclusion The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Systematic review registration The study was registered at UMIN under the registration number UMIN000043347. Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation.BACKGROUNDMitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death. Based on their multifactorial roles, mitochondria are also critical in the progression of critical illnesses. Transplantation of mitochondria has been reported as a potential promising approach to treat critical illnesses, particularly ischemia reperfusion injury (IRI). However, a systematic review of the relevant literature has not been conducted to date. Here, we systematically reviewed the animal and human studies relevant to IRI to summarize the evidence for mitochondrial transplantation.We searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis.METHODSWe searched MEDLINE, the Cochrane library, and Embase and performed a systematic review of mitochondrial transplantation for IRI in both preclinical and clinical studies. We developed a search strategy using a combination of keywords and Medical Subject Heading/Emtree terms. Studies including cell-mediated transfer of mitochondria as a transfer method were excluded. Data were extracted to a tailored template, and data synthesis was descriptive because the data were not suitable for meta-analysis.Overall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI-associated myocardial dysfunction after cardiac surgery.RESULTSOverall, we identified 20 animal studies and two human studies. Among animal studies, 14 (70%) studies focused on either brain or heart IRI. Both autograft and allograft mitochondrial transplantation were used in 17 (85%) animal studies. The designs of the animal studies were heterogeneous in terms of the route of administration, timing of transplantation, and dosage used. Twelve (60%) studies were performed in a blinded manner. All animal studies reported that mitochondrial transplantation markedly mitigated IRI in the target tissues, but there was variation in biological biomarkers and pathological changes. The human studies were conducted with a single-arm, unblinded design, in which autologous mitochondrial transplantation was applied to pediatric patients who required extracorporeal membrane oxygenation (ECMO) for IRI-associated myocardial dysfunction after cardiac surgery.The evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Systematic review registration The study was registered at UMIN under the registration number UMIN000043347.CONCLUSIONThe evidence gathered from our systematic review supports the potential beneficial effects of mitochondrial transplantation after IRI, but its clinical translation remains limited. Further investigations are thus required to explore the mechanisms of action and patient outcomes in critical settings after mitochondrial transplantation. Systematic review registration The study was registered at UMIN under the registration number UMIN000043347. |
| ArticleNumber | 214 |
| Audience | Academic |
| Author | Kuschner, Cyrus E. Becker, Lance B. Molmenti, Ernesto P. Kim, Junhwan Shinozaki, Koichiro Nishikimi, Mitsuaki Rolston, Daniel M. Guevara, Sara Miyara, Santiago J. Aoki, Tomoaki Shoaib, Muhammad Takegawa, Ryosuke Hayashida, Kei Choudhary, Rishabh C. |
| Author_xml | – sequence: 1 givenname: Kei orcidid: 0000-0002-2287-3318 surname: Hayashida fullname: Hayashida, Kei email: khayashida@northwell.edu organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System – sequence: 2 givenname: Ryosuke surname: Takegawa fullname: Takegawa, Ryosuke organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System – sequence: 3 givenname: Muhammad surname: Shoaib fullname: Shoaib, Muhammad organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System, Zucker School of Medicine At Hofstra/Northwell – sequence: 4 givenname: Tomoaki surname: Aoki fullname: Aoki, Tomoaki organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System – sequence: 5 givenname: Rishabh C. surname: Choudhary fullname: Choudhary, Rishabh C. organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System – sequence: 6 givenname: Cyrus E. surname: Kuschner fullname: Kuschner, Cyrus E. organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System, Zucker School of Medicine At Hofstra/Northwell – sequence: 7 givenname: Mitsuaki surname: Nishikimi fullname: Nishikimi, Mitsuaki organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System – sequence: 8 givenname: Santiago J. surname: Miyara fullname: Miyara, Santiago J. organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System – sequence: 9 givenname: Daniel M. surname: Rolston fullname: Rolston, Daniel M. organization: Department of Emergency Medicine, North Shore University Hospital, Northwell Health System, Zucker School of Medicine At Hofstra/Northwell – sequence: 10 givenname: Sara surname: Guevara fullname: Guevara, Sara organization: Department of Surgery, Northwell Health – sequence: 11 givenname: Junhwan surname: Kim fullname: Kim, Junhwan organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System, Zucker School of Medicine At Hofstra/Northwell – sequence: 12 givenname: Koichiro surname: Shinozaki fullname: Shinozaki, Koichiro organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System, Zucker School of Medicine At Hofstra/Northwell – sequence: 13 givenname: Ernesto P. surname: Molmenti fullname: Molmenti, Ernesto P. organization: Zucker School of Medicine At Hofstra/Northwell, Department of Surgery, Northwell Health – sequence: 14 givenname: Lance B. surname: Becker fullname: Becker, Lance B. organization: The Feinstein Institutes for Medical Research, Northwell Health System, Department of Emergency Medicine, North Shore University Hospital, Northwell Health System, Zucker School of Medicine At Hofstra/Northwell |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34001191$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktr3DAUhU1JaR7tH-iiGLrpxqlelqUuCiH0EUjppl0LWY8ZDR5pKtkT5t_3zjjNixKMsZC-c3Tv9TmtjmKKrqreYnSOseAfCyaSdw0iGF7RiYa-qE4w62TTio4fPVgfV6elrBAirGXyVXVMGUIYS3xSbX-EMZllijYHPdRj1rFsBh1HPYYU63Hpst7sap9yHYpZunXQdXYbl_1U9kCIqynvPtW6LrsyujXIDADb4G7q5GsdwxpsdbT1clrrWJdxssGV19VLr4fi3tx-z6rfX7_8uvzeXP_8dnV5cd0YjrqxMdQayjzCPbfWEmZ7TzjpqRZccms6xqAJg2XbtkJbbR3XXlgnW9PDiTH0rLqafW3SK7XJUE3eqaSDOmykvFA6Q8mDU7gn0nTcix5bxj3ve-Sw8IZySnuGHHh9nr02U7921rgI0xoemT4-iWGpFmmrBKYIcwkGH24NcvozuTKqNczUDTBul6aiSEuEIARLAuj7J-gqTTnCqA6URJIReU8tNDQQok9wr9mbqgvOW0YZRQio8_9Q8Fj4mwYi5QPsPxK8e9joXYf_UgMAmQGTUynZ-TsEI7WPppqjqSCa6hBNRUEknohMmFMG5YTheSmdpQXuiQuX76fxjOov26L5_g |
| CitedBy_id | crossref_primary_10_2147_IJGM_S499905 crossref_primary_10_1186_s12967_024_05003_2 crossref_primary_10_2174_1570159X05666220908100545 crossref_primary_10_1007_s00246_022_02926_9 crossref_primary_10_1186_s13287_024_03771_8 crossref_primary_10_1016_j_healun_2024_10_033 crossref_primary_10_2174_0113816128275761231103102125 crossref_primary_10_1002_advs_202416594 crossref_primary_10_1007_s40472_024_00428_6 crossref_primary_10_1016_j_cellsig_2023_110959 crossref_primary_10_1186_s12967_024_05740_4 crossref_primary_10_3390_cells11071165 crossref_primary_10_1016_j_mito_2022_05_004 crossref_primary_10_1007_s00109_023_02326_3 crossref_primary_10_1016_j_mito_2022_05_002 crossref_primary_10_1097_SCS_0000000000010706 crossref_primary_10_1016_j_healun_2023_01_002 crossref_primary_10_1038_s41586_023_06866_z crossref_primary_10_1111_srt_70022 crossref_primary_10_1186_s40560_024_00745_z crossref_primary_10_5812_ijpr_159628 crossref_primary_10_1016_j_biopha_2023_115651 crossref_primary_10_1556_650_2022_32552 crossref_primary_10_1177_17448069231210423 crossref_primary_10_3389_fcimb_2023_1130197 crossref_primary_10_1016_j_resuscitation_2025_110535 crossref_primary_10_3389_fimmu_2023_1216094 crossref_primary_10_3390_biomedicines12081705 crossref_primary_10_1186_s12872_024_04051_2 crossref_primary_10_1186_s12916_023_02759_0 crossref_primary_10_1016_j_celbio_2025_100016 crossref_primary_10_1016_j_mito_2022_04_004 crossref_primary_10_3390_cells11040688 crossref_primary_10_3390_life14040477 crossref_primary_10_3390_cimb45050283 crossref_primary_10_3389_fcell_2022_1082095 crossref_primary_10_1016_j_lfs_2023_122116 crossref_primary_10_3390_ijms242115788 crossref_primary_10_3390_ph15030271 crossref_primary_10_1038_s44222_025_00293_7 crossref_primary_10_1038_s41598_025_86760_y crossref_primary_10_1161_CIRCULATIONAHA_123_065298 crossref_primary_10_1007_s00395_024_01062_0 crossref_primary_10_1097_ACO_0000000000001202 crossref_primary_10_1097_MOT_0000000000001015 crossref_primary_10_1016_j_jhep_2023_02_009 crossref_primary_10_1186_s12967_024_05979_x crossref_primary_10_18137_cardiometry_2022_22_1827 crossref_primary_10_3390_ijms241210113 crossref_primary_10_1155_2022_3277274 crossref_primary_10_1038_s41392_024_01839_8 crossref_primary_10_3390_ijms24076362 crossref_primary_10_3389_fcvm_2023_1268814 crossref_primary_10_3892_mmr_2022_12896 crossref_primary_10_1007_s12012_024_09896_9 crossref_primary_10_1155_2021_1006636 crossref_primary_10_1186_s12951_024_02750_8 |
| Cites_doi | 10.1016/j.jvs.2019.03.079 10.1016/j.bbadis.2020.165809 10.1016/j.jmb.2017.01.017 10.1152/ajpheart.00468.2006 10.1038/nature18928 10.1093/ilar/ilu043 10.1016/j.cellsig.2012.03.007 10.1152/ajpheart.00567.2008 10.1016/j.chest.2019.08.2182 10.1038/s41598-017-17813-0 10.1016/j.bioactmat.2020.12.024 10.1152/ajplung.00221.2019 10.1016/j.resuscitation.2011.07.039 10.1016/j.cell.2012.02.035 10.1152/ajpheart.00883.2012 10.1161/STROKEAHA.120.030152 10.7554/eLife.08351 10.1038/nrd.2018.174 10.1186/s40169-016-0095-4 10.1016/j.molmed.2019.10.006 10.1016/j.jtcvs.2019.06.111 10.1111/jcmm.15617 10.1371/journal.pone.0098856 10.1371/journal.pmed.1000245 10.1016/j.mito.2017.03.004 10.1016/j.athoracsur.2019.06.075 10.1016/j.tips.2012.03.010 10.1016/j.cardiores.2003.10.025 10.1016/j.bbr.2018.09.005 10.1038/s12276-018-0094-1 10.1016/j.resuscitation.2016.12.029 10.1016/j.biocel.2014.05.009 10.1002/pmic.201000320 10.1016/j.jclinepi.2009.06.006 10.1016/j.mito.2018.03.002 10.1016/j.brainresbull.2020.09.018 10.1016/j.resuscitation.2016.01.006 10.1042/BJ20081386 10.1242/bio.201511478 10.1164/rccm.200410-1344OC 10.1016/j.jtcvs.2016.10.077 10.1001/jamaneurol.2017.3475 10.1186/s12967-019-02205-x 10.3727/096368915X689785 10.1016/j.wneu.2019.11.172 10.1016/j.jtcvs.2017.02.018 10.1186/s13643-016-0384-4 10.1016/j.jtcvs.2019.10.151 10.1016/j.jacbts.2019.08.007 10.1016/j.healun.2018.09.025 10.1007/978-3-319-55330-6_31 10.1152/ajprenal.00255.2020 10.1073/pnas.0407043101 10.1038/ncb2220 10.1371/journal.pone.0160889 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12967-021-02878-3 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1479-5876 |
| EndPage | 15 |
| ExternalDocumentID | oai_doaj_org_article_1b29c76f8b1d46f6bb0e18fc3633b40e PMC8130169 A665434300 34001191 10_1186_s12967_021_02878_3 |
| Genre | Systematic Review Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GroupedDBID | --- 0R~ 29L 2WC 53G 5VS 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c607t-c3dc34f01b6ddd24dbf262b3a8696dc744191c195558adade6af8de95cb419cc3 |
| IEDL.DBID | M48 |
| ISSN | 1479-5876 |
| IngestDate | Wed Aug 27 01:14:07 EDT 2025 Thu Aug 21 14:32:58 EDT 2025 Thu Sep 04 18:49:59 EDT 2025 Fri Jul 25 06:29:30 EDT 2025 Tue Jun 17 21:28:00 EDT 2025 Tue Jun 10 20:16:20 EDT 2025 Mon Jul 21 06:02:09 EDT 2025 Tue Jul 01 03:51:17 EDT 2025 Thu Apr 24 22:53:10 EDT 2025 Sat Sep 06 07:28:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Translation science Systematic review Mitochondria Transplantation Ischemia reperfusion injury |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-c3dc34f01b6ddd24dbf262b3a8696dc744191c195558adade6af8de95cb419cc3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
| ORCID | 0000-0002-2287-3318 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12967-021-02878-3 |
| PMID | 34001191 |
| PQID | 2528909429 |
| PQPubID | 43076 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1b29c76f8b1d46f6bb0e18fc3633b40e pubmedcentral_primary_oai_pubmedcentral_nih_gov_8130169 proquest_miscellaneous_2528822192 proquest_journals_2528909429 gale_infotracmisc_A665434300 gale_infotracacademiconefile_A665434300 pubmed_primary_34001191 crossref_primary_10_1186_s12967_021_02878_3 crossref_citationtrail_10_1186_s12967_021_02878_3 springer_journals_10_1186_s12967_021_02878_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-05-17 |
| PublicationDateYYYYMMDD | 2021-05-17 |
| PublicationDate_xml | – month: 05 year: 2021 text: 2021-05-17 day: 17 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Journal of translational medicine |
| PublicationTitleAbbrev | J Transl Med |
| PublicationTitleAlternate | J Transl Med |
| PublicationYear | 2021 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | G Ramirez-Barbieri (2878_CR54) 2019; 46 JA Hirst (2878_CR55) 2014; 9 K Hayakawa (2878_CR4) 2016; 535 MA Peberdy (2878_CR10) 2016; 103 K Moskowitzova (2878_CR41) 2019; 38 LB Becker (2878_CR14) 2004; 61 RA Smith (2878_CR8) 2012; 33 A Masuzawa (2878_CR40) 2013; 304 A Guariento (2878_CR35) 2020; S1053–2498 J Radhakrishnan (2878_CR11) 2007; 292 B Zhang (2878_CR30) 2020; 138 CA Pacak (2878_CR53) 2015; 4 J Nunnari (2878_CR7) 2012; 148 GS Supinski (2878_CR20) 2020; 157 MP Murphy (2878_CR13) 2009; 417 P Pound (2878_CR26) 2020; 18 JD McCully (2878_CR24) 2016; 5 Z Zhang (2878_CR32) 2019; 356 TF Reubold (2878_CR16) 2012; 24 SM Emani (2878_CR49) 2017; 154 B Shin (2878_CR5) 2017; 982 Z Pourmohammadi-Bejarpasi (2878_CR31) 2020; 165 D Blitzer (2878_CR34) 2020; 109 CS Liu (2878_CR1) 2014; 53 L Huang (2878_CR51) 2019; 20 AL Chernorudskiy (2878_CR15) 2017; 429 JD McCully (2878_CR22) 2017; 34 LA Callahan (2878_CR18) 2005; 172 AK Kaza (2878_CR36) 2017; 153 Y Nakamura (2878_CR25) 2020; 51 DB Cowan (2878_CR52) 2017; 7 HB van der Worp (2878_CR56) 2010; 7 A Guariento (2878_CR38) 2020; 160 H Jabbari (2878_CR43) 2020; 1866 C Willmes (2878_CR21) 2020; 26 SY Fang (2878_CR47) 2021; 161 LC Gomes (2878_CR19) 2011; 13 CH Huang (2878_CR12) 2012; 83 K Moskowitzova (2878_CR46) 2020; 318 VC Henderson (2878_CR57) 2015; 4 JD McCully (2878_CR3) 2009; 296 A Orfany (2878_CR45) 2020; 71 A Liberati (2878_CR28) 2009; 62 PJ Huang (2878_CR33) 2016; 25 A Guariento (2878_CR50) 2020; S0022-5223 B Shin (2878_CR37) 2019; 4 N Verma (2878_CR58) 2011; 11 X Sun (2878_CR42) 2021; 6 S Cipolat (2878_CR2) 2004; 101 RB de Vries (2878_CR27) 2014; 55 M Ouzzani (2878_CR29) 2016; 5 PJ Esteves (2878_CR59) 2018; 50 IP Doulamis (2878_CR44) 2020; 319 MP Murphy (2878_CR6) 2018; 17 DB Cowan (2878_CR39) 2016; 11 SF Ko (2878_CR48) 2020; 24 MW Donnino (2878_CR9) 2017; 113 K Hayakawa (2878_CR23) 2018; 75 X Wang (2878_CR17) 2001; 15 |
| References_xml | – volume: 71 start-page: 1014 issue: 3 year: 2020 ident: 2878_CR45 publication-title: J Vasc Surg doi: 10.1016/j.jvs.2019.03.079 – volume: 1866 start-page: 165809 year: 2020 ident: 2878_CR43 publication-title: Biochim Biophys Acta Mol Basis Dis. doi: 10.1016/j.bbadis.2020.165809 – volume: 429 start-page: 620 issue: 5 year: 2017 ident: 2878_CR15 publication-title: J Mol Biol doi: 10.1016/j.jmb.2017.01.017 – volume: 292 start-page: H767 issue: 2 year: 2007 ident: 2878_CR11 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00468.2006 – volume: 535 start-page: 551 issue: 7613 year: 2016 ident: 2878_CR4 publication-title: Nature doi: 10.1038/nature18928 – volume: 55 start-page: 427 issue: 3 year: 2014 ident: 2878_CR27 publication-title: ILAR J doi: 10.1093/ilar/ilu043 – volume: 24 start-page: 1420 issue: 7 year: 2012 ident: 2878_CR16 publication-title: Cell Signal doi: 10.1016/j.cellsig.2012.03.007 – volume: 296 start-page: H94 issue: 1 year: 2009 ident: 2878_CR3 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00567.2008 – volume: 157 start-page: 310 issue: 2 year: 2020 ident: 2878_CR20 publication-title: Chest doi: 10.1016/j.chest.2019.08.2182 – volume: 7 start-page: 17450 issue: 1 year: 2017 ident: 2878_CR52 publication-title: Sci Rep doi: 10.1038/s41598-017-17813-0 – volume: 6 start-page: 2058 issue: 7 year: 2021 ident: 2878_CR42 publication-title: Bioact Mater doi: 10.1016/j.bioactmat.2020.12.024 – volume: 318 start-page: L78 issue: 1 year: 2020 ident: 2878_CR46 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00221.2019 – volume: 83 start-page: 213 issue: 2 year: 2012 ident: 2878_CR12 publication-title: Resuscitation doi: 10.1016/j.resuscitation.2011.07.039 – volume: 148 start-page: 1145 issue: 6 year: 2012 ident: 2878_CR7 publication-title: Cell doi: 10.1016/j.cell.2012.02.035 – volume: 304 start-page: H966 issue: 7 year: 2013 ident: 2878_CR40 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00883.2012 – volume: 51 start-page: 3142 year: 2020 ident: 2878_CR25 publication-title: Stroke doi: 10.1161/STROKEAHA.120.030152 – volume: 4 start-page: e08351 year: 2015 ident: 2878_CR57 publication-title: eLife. doi: 10.7554/eLife.08351 – volume: 17 start-page: 865 issue: 12 year: 2018 ident: 2878_CR6 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd.2018.174 – volume: 5 start-page: 16 issue: 1 year: 2016 ident: 2878_CR24 publication-title: Clin Transl Med doi: 10.1186/s40169-016-0095-4 – volume: 20 start-page: 2 year: 2019 ident: 2878_CR51 publication-title: Int J Mol Sci. – volume: 26 start-page: 1 issue: 1 year: 2020 ident: 2878_CR21 publication-title: Trends Mol Med doi: 10.1016/j.molmed.2019.10.006 – volume: 160 start-page: e15 issue: 2 year: 2020 ident: 2878_CR38 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2019.06.111 – volume: 24 start-page: 10088 issue: 17 year: 2020 ident: 2878_CR48 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15617 – volume: 9 start-page: e98856 issue: 6 year: 2014 ident: 2878_CR55 publication-title: PLOS ONE. doi: 10.1371/journal.pone.0098856 – volume: 7 start-page: e1000245 issue: 3 year: 2010 ident: 2878_CR56 publication-title: PLOS Med. doi: 10.1371/journal.pmed.1000245 – volume: 34 start-page: 127 year: 2017 ident: 2878_CR22 publication-title: Mitochondrion doi: 10.1016/j.mito.2017.03.004 – volume: 109 start-page: 711 issue: 3 year: 2020 ident: 2878_CR34 publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2019.06.075 – volume: 33 start-page: 341 issue: 6 year: 2012 ident: 2878_CR8 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2012.03.010 – volume: 61 start-page: 461 issue: 3 year: 2004 ident: 2878_CR14 publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2003.10.025 – volume: 356 start-page: 322 year: 2019 ident: 2878_CR32 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2018.09.005 – volume: 50 start-page: 1 issue: 5 year: 2018 ident: 2878_CR59 publication-title: Exp Mol Med doi: 10.1038/s12276-018-0094-1 – volume: 113 start-page: 56 year: 2017 ident: 2878_CR9 publication-title: Resuscitation doi: 10.1016/j.resuscitation.2016.12.029 – volume: 53 start-page: 141 year: 2014 ident: 2878_CR1 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2014.05.009 – volume: 11 start-page: 776 issue: 4 year: 2011 ident: 2878_CR58 publication-title: Proteomics doi: 10.1002/pmic.201000320 – volume: 62 start-page: e1 issue: 10 year: 2009 ident: 2878_CR28 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2009.06.006 – volume: 46 start-page: 103 year: 2019 ident: 2878_CR54 publication-title: Mitochondrion doi: 10.1016/j.mito.2018.03.002 – volume: 165 start-page: 70 year: 2020 ident: 2878_CR31 publication-title: Brain Res Bull doi: 10.1016/j.brainresbull.2020.09.018 – volume: 103 start-page: 117 year: 2016 ident: 2878_CR10 publication-title: Resuscitation doi: 10.1016/j.resuscitation.2016.01.006 – volume: 417 start-page: 1 issue: 1 year: 2009 ident: 2878_CR13 publication-title: Biochem J doi: 10.1042/BJ20081386 – volume: 4 start-page: 622 issue: 5 year: 2015 ident: 2878_CR53 publication-title: Biol Open doi: 10.1242/bio.201511478 – volume: 172 start-page: 861 issue: 7 year: 2005 ident: 2878_CR18 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200410-1344OC – volume: 15 start-page: 2922 issue: 22 year: 2001 ident: 2878_CR17 publication-title: Genes Dev – volume: 153 start-page: 934 issue: 4 year: 2017 ident: 2878_CR36 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2016.10.077 – volume: 75 start-page: 119 issue: 1 year: 2018 ident: 2878_CR23 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2017.3475 – volume: 18 start-page: 15 issue: 1 year: 2020 ident: 2878_CR26 publication-title: J Transl Med doi: 10.1186/s12967-019-02205-x – volume: 25 start-page: 913 issue: 5 year: 2016 ident: 2878_CR33 publication-title: Cell Transplant doi: 10.3727/096368915X689785 – volume: S1053–2498 start-page: 31625 issue: 20 year: 2020 ident: 2878_CR35 publication-title: J Heart Lung Transplant. – volume: 138 start-page: e1 year: 2020 ident: 2878_CR30 publication-title: World Neurosurg doi: 10.1016/j.wneu.2019.11.172 – volume: 154 start-page: 286 issue: 1 year: 2017 ident: 2878_CR49 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2017.02.018 – volume: 5 start-page: 210 issue: 1 year: 2016 ident: 2878_CR29 publication-title: Syst Rev doi: 10.1186/s13643-016-0384-4 – volume: 161 start-page: e337 issue: 5 year: 2021 ident: 2878_CR47 publication-title: J Thorac Cardiovasc Surg. doi: 10.1016/j.jtcvs.2019.10.151 – volume: 4 start-page: 871 issue: 8 year: 2019 ident: 2878_CR37 publication-title: JACC Basic Transl Sci doi: 10.1016/j.jacbts.2019.08.007 – volume: 38 start-page: 92 issue: 1 year: 2019 ident: 2878_CR41 publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2018.09.025 – volume: 982 start-page: 595 year: 2017 ident: 2878_CR5 publication-title: Adv Exp Med Biol doi: 10.1007/978-3-319-55330-6_31 – volume: 319 start-page: F403 issue: 3 year: 2020 ident: 2878_CR44 publication-title: Am J Physiol Ren Physiol doi: 10.1152/ajprenal.00255.2020 – volume: S0022-5223 start-page: 33142-1 issue: 20 year: 2020 ident: 2878_CR50 publication-title: J Thorac Cardiovasc Surg. – volume: 101 start-page: 15927 issue: 45 year: 2004 ident: 2878_CR2 publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.0407043101 – volume: 13 start-page: 589 issue: 5 year: 2011 ident: 2878_CR19 publication-title: Nat Cell Biol doi: 10.1038/ncb2220 – volume: 11 start-page: e0160889 issue: 8 year: 2016 ident: 2878_CR39 publication-title: PLOS ONE. doi: 10.1371/journal.pone.0160889 |
| SSID | ssj0024549 |
| Score | 2.5353878 |
| SecondaryResourceType | review_article |
| Snippet | Background
Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell... Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell death.... Background Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and facilitate cell... Abstract Background Mitochondria are essential organelles that provide energy for cellular functions, participate in cellular signaling and growth, and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 214 |
| SubjectTerms | Animals Apoptosis Autografts Biomedical and Life Sciences Biomedicine Care and treatment Cell Cell Death Cells Child Dosage Health aspects Heart attacks Heart surgery Heart transplantation Humans Illnesses Ischemia Ischemia reperfusion injury Medicine/Public Health Meta-analysis Mitochondria Mitochondrial DNA Nervous system Organelles Oxidative stress Oxygenation Patients Physiological aspects Physiology Reperfusion Reperfusion injury Reperfusion Injury - therapy Review Software Stroke Systematic review tissue and gene therapy Translation science Transplantation Transplants & implants Traumatic brain injury |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICMhcYCocew4MbeCqCqk5USl3ix7bIugNlvtA6n_vmM72TZFwIXr2sna85545jMhbwFCDZyxsnZSlQI9XGmF78rWc6PaClhIvVWLb_L4RHw9bU5vXPUVa8IyPHAm3AGztYJWhs4yJ2SQ1laedQG45NyKykfrW6lqSqYmlD1Me6YWmU4erNGroUGI5QjoT2NBwMwNJbT-323yDad0u2Dy1qlpckZHD8j9MYqkh3n1D8kdPzwidxfjOflj8muBioqGbXBRvugmIZifmdxmNNDcdHVJMWClPaa3_rw3dOUv_Cps49cz2g8_kdYfqaHXSM80d7nQZaBm6M_xtWZwNN3xR9e5GvEJOTn68v3zcTnesFCCrNpNCdwBF6FiVjrnauFsqGVtuemkkg5ajJUUA6YiKJhxxnlpQue8asDiCAB_SvaG5eCfE1qDEBZzFW8bZK8BJazjyjjR4AtA-oKwieAaRvjxeAvGmU5pSCd1ZpJGJunEJM0L8n73zEUG3_jr7E-Rj7uZETg7_YDipEdx0v8Sp4K8i1Kgo3rj8sCMXQq4yQiUpQ9lbsatqoLsz2aiWsJ8eJIjPZqFta6beK6rMAYoyJvdcHwylroNfrnNczBqw8i7IM-y2O22xEXC6GMFaWcCOdvzfGTofyTQ8A6DFSbxfz9Monu9rD_T9MX_oOlLcq9OqteUrN0ne5vV1r_CUG5jXyetvQKRc0a6 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9QwFA-6gngRv62uEkHwoGWbJk1bL7KKyyKMJxfmFpKXRLvstuN8CP73viSdGbviXpu0TfK-k_d-IeQ1gC-BM5aXVra5QAuXG-GavHZct3UBzMfaqtlXeXomvsyr-bjhthrTKrc6MSpqO0DYIz8qq3Ak1qL6_LD4mYdbo8Lp6niFxk1yK0KXIT_X833AJTD42RbKNPJohbYN1UJISkCrGtICJsYoYvb_q5n_Mk1X0yavnJ1Gk3Ryj9wdfUl6nIh_n9xw_QNyezaelj8kv2Yorqjeehu4jK4jjvmFTsVGPU2lV78puq20wyDXXXaaLt3CLf0m7KHRrj_HFX9PNd3jPdNU60IHT3XfXeJndW9pvOmPrlJO4iNydvL526fTfLxnIQdZ1OscuAUufMGMtNaWwhpfytJw3chWWqjRY2oZ4PpWVaOttk5q31jXVmCwBYA_Jgf90LunhJYghMGIxZkKiayhFcbyVltR4QdAuoyw7YIrGEHIw10YFyoGI41UiUgKiaQikRTPyNvdO4sEwXFt74-BjrueAT47PhiW39UojYqZsoVa-sYwK6SXxhSONR645NyIAof5JnCBCkKOwwM91irgJANcljqWqSS3KDJyOOmJwgnT5i0fqVE5rNSelTPyatcc3gwJb70bNqkP-m7of2fkSWK73ZS4iEh9LCP1hCEnc5629N2PCB3eoMvCJP733ZZ198P6_5o-u34Wz8mdMgpVlbP6kByslxv3Al21tXkZ5fEP29I92g priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgL4k1KQUZC4gARcew4CbdSUVVIy4lKvVn22BZBrbfaBxL_vmM7u9uUh8Q1Hie2Z8Yzk_F8JuQNgK-BM1bWVvalQAtXGuG6snVc920FzKfaqtlXeXIqvpw1ZyNMTqyFuZ6_Z538sER7hKocDxKgJYyp_NvkTsO4TIlZebTD1cNAZ1MU88d-E8OT8Pl_34WvmaGbRyRv5EmT-Tl-QO6PfiM9zIx-SG658IjcnY2Z8cfk5wxVE7eyYKNE0VXCLD_XubAo0Fxm9Yuii0oHDGjdxaDpwl26hV_H_2V0CD9wdT9STXfYzjTXtdC5pzoMF_haHSxNt_rRZT5_-IScHn_-dnRSjncqlCCrdlUCt8CFr5iR1tpaWONrWRuuO9lLCy16Rz0D1kcYMG21dVL7zrq-AYMtAPwp2Qvz4J4TWoMQBqMTZxpkqIZeGMt7bUWDLwDpCsI2C65gBByP916cqxR4dFJlJilkkkpMUrwg77Z9LjPcxj-pP0U-bikjVHZ6gBKkRs1TzNQ9tNJ3hlkhvTSmcqzzgCLEjahwmG-jFKio0Dg80GNdAk4yQmOpQ5nLb6uqIAcTSlREmDZv5EiNG8FS1U3M5PZo9Qvyetsce8bDbcHN15kG_TT0tQvyLIvddkpcJFQ-VpB2IpCTOU9bwvA9wYR36J4wid99vxHd3bD-vqb7_0f-gtyrk5I1JWsPyN5qsXYv0U1bmVdJP68Aq582ug priority: 102 providerName: Springer Nature |
| Title | Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies |
| URI | https://link.springer.com/article/10.1186/s12967-021-02878-3 https://www.ncbi.nlm.nih.gov/pubmed/34001191 https://www.proquest.com/docview/2528909429 https://www.proquest.com/docview/2528822192 https://pubmed.ncbi.nlm.nih.gov/PMC8130169 https://doaj.org/article/1b29c76f8b1d46f6bb0e18fc3633b40e |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA57AfFFvFtdhwiCD1ptmjRtBZGdYZdFmEUWBwZfQq5ame2scxH333uStjN2XX3yZaCTpE3OpeecJuc7CD3X2qWaEhKnhpcxAwsXK2aLOLdUlnmiiQu5VeNTfjJhH6bZdAd15Y5aAi6vDe18PanJYvb65_fL96Dw74LCF_zNEmwWqLs_bADW0m_376J9sEzcB2NjVmyx9yAY6hJnrh3XM04Bw__PN_VvpurqMcore6nBRB3fRrda3xIfNsJwB-3Y-i66MW53z--hH2NQX1hxbbzU4VXANZ_JJvmoxk0q1iUGNxZXQBl7Xkm8sBd24db-mxqu6m_AgbdY4i3-M25yX_DcYVlX53BbWRscKv_hZXNG8T6aHB99Gp3Ebd2FWPMkX8WaGk2ZS4jixpiUGeVSnioqC15yo3PwoEqiSemhwqSRxnLpCmPLTCto0Zo-QHv1vLaPEE41YwoiGKsyYLrUJVOGltKwDG6guY0Q6QgudAtK7mtjzEQITgouGiYJYJIITBI0Qi83Yy4aSI5_9h56Pm56ejjt8Md88UW02imISkudc1coYhh3XKnEksJpyilVLIFpvvBSILwYwvS0bHMXYJEePksc8iZFN0kidNDrCcqq-82dHIlO1kWa-d3eEjyDCD3bNPuR_gBcbefrpg_4cuCPR-hhI3abJVEWkPtIhPKeQPbW3G-pq68BSrwAF4ZweO6rTnS30_o7TR__D5o-QTfToHpZTPIDtLdarO1TcPBWaoB282k-QPvDo9OPZ3A14qNB-FgyCPoMv2fDz78A0J1ToQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgIuiDeBAkYCcYCocew4CRJCLbTa0u4KoVbqzfgVWNRml32A-qf4jYztZJcU0Vuva8drZ8bfjOOZbxB6rnWVakpInBpexgwsXKyYLeLcUlnmiSaVz60aDHn_iH08zo7X0O82F8aFVbaY6IHajLX7Rr6ZZu5KrAT4fDf5EbuqUe52tS2hEdRi3579giPb7O3eB5DvizTd3Tl834-bqgKx5kk-jzU1mrIqIYobY1JmVJXyVFFZ8JIbnYN_UBJNSkeEJY00lsuqMLbMtIIWrSmMewWtM5fR2kPr2zvDT59X7H5w3GpTcwq-OQNrCkDkwiDAjrtAhI7581UC_rUFfxnD84Ga525rvRHcvYluNN4r3grqdgut2fo2ujpo7ufvoJ8DAAgA1No4vcZzz5x-IkN6U41DstcZBkcZj-BYbU9HEk_txE6rhftqh0f1d5DxGyzximEah-waPK6wrEenMKysDfa1BfEsREHeRUeXIoN7qFePa_sA4VQzpuCMZFUGaiV1yZShpTQsgwE0txEi7QsXuqE9d9U3ToQ__hRcBCEJEJLwQhI0Qq-Wz0wC6ceFvbedHJc9HWG3_2E8_Sqa_S-ISkud86pQxDBecaUSS4pKU06pYglM86XTAuFgBaanZZMdAYt0BF1ii4ck4CSJ0EanJ8CB7ja3eiQaOJqJ1eaJ0LNls3vShdjVdrwIfcBbBI8_QveD2i2XRJnnBiQRyjsK2Vlzt6UeffNk5QU4SYTD_75uVXc1rf-_04cXr-IputY_HByIg73h_iN0PfUbLItJvoF68-nCPgZHca6eNLsToy-XDQh_AKykfdU |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXxJtAASMhcYCocew4CbdSWJXHVhyo1JvlJwS13tVuFol_z9jO7jblIXGNx4ntmfGMMzOfEXqutSs1JSQvDW9zBhYuV8w2eW2pbOtCExdrq6bH_OiEfTitTi9U8cds93VIMtU0BJQm3-_PjUsq3vD9JVgpUPCQXgD2MQT4r6JrLJi-EK7lh1u0PTj-rEtl_thvZI4iav_ve_MF43Q5cfJS9DQapclNdGPwJvFBYv8tdMX622h3OsTL76AfU1BY2OC8CXKG-4hkfiZTuZHHqfjqJwbHFXdwzLXnncQLO7cLtwp_0XDnv8Oav8YSbxGfcap2wTOHpe_O4bXSGxzv-sPLlJV4F51M3n05PMqHmxZyzYu6zzU1mjJXEMWNMSUzypW8VFQ2vOVG1-AztUSTNoCDSSON5dI1xraVVtCiNb2HdvzM2wcIl5oxBWcWqypgs9QtU4a20rAKXqC5zRBZL7jQAwx5uA3jTMTjSMNFYpIAJonIJEEz9HLTZ55AOP5J_SbwcUMZALTjg9niqxj0URBVtrrmrlHEMO64UoUljdOUU6pYAcN8EaRABDWH4Wk5VCvAJANgljjgqSi3KDK0N6IE9dTj5rUciWF7WIqyCvHdFnyBDD3bNIeeIeXN29kq0YD3Bh54hu4nsdtMibKI1UcyVI8EcjTncYvvvkXw8AacFsLhu6_Worsd1t_X9OH_kT9Fu5_fTsSn98cfH6HrZdS3Kif1HtrpFyv7GPy4Xj2JqvoLMAlB7g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitochondrial+transplantation+therapy+for+ischemia+reperfusion+injury%3A+a+systematic+review+of+animal+and+human+studies&rft.jtitle=Journal+of+translational+medicine&rft.au=Kei+Hayashida&rft.au=Ryosuke+Takegawa&rft.au=Muhammad+Shoaib&rft.au=Tomoaki+Aoki&rft.date=2021-05-17&rft.pub=BMC&rft.eissn=1479-5876&rft.volume=19&rft.issue=1&rft.spage=1&rft.epage=15&rft_id=info:doi/10.1186%2Fs12967-021-02878-3&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_1b29c76f8b1d46f6bb0e18fc3633b40e |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon |